 double-blind placebo-controlled trial nimodipine acute stroke Trust Study Group value oral nimodipine mg day acute stroke randomised double-blind placebo-controlled multicentre study patients primary end-point independence months score activities daily living ADL scale Barthel index Patients trial hemiparetic previous conscious able stroke months nimodipine group placebo group independent odds ratio independence nimodipine confidence limits mortality odds nimodipine confidence limits ADL neurological scores delayed recovery nimodipine group weeks results case oral nimodipine therapy mg day stroke patients acute stroke